|
| | Publication Year | Title | Author(s) |
| 1 | 22-Sep-2017 | [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo. | Martin, Ana Carolina B M; Fuzer, Angelina M; Becceneri, Amanda B; da Silva, James Almada; Tomasin, Rebeka; Denoyer, Delphine; Kim, Soo-Hyun; McIntyre, Katherine A; Pearson, Helen B; Yeo, Belinda ; Nagpal, Aadya; Ling, Xiawei; Selistre-de-Araújo, Heloisa S; Vieira, Paulo Cézar; Cominetti, Marcia R; Pouliot, Normand |
| 2 | 19-Mar-2009 | 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma. | Azad, Arun A; Chong, Geoffrey ; Tauro, A; Aly, Ahmad ; Tebbutt, Niall C |
| 3 | 4-Aug-2023 | [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | Koh, Eng-Siew; Gan, Hui K ; Senko, Clare ; Francis, Roslyn J; Ebert, Martin; Lee, Sze Ting ; Lau, Eddie ; Khasraw, Mustafa; Nowak, Anna K; Bailey, Dale L; Moffat, Bradford A; Fitt, Gregory J ; Hicks, Rodney J; Coffey, Robert; Verhaak, Roel; Walsh, Kyle M; Barnes, Elizabeth H; De Abreu Lourenco, Richard; Rosenthal, Mark; Adda, Lucas; Foroudi, Farshad ; Lasocki, Arian; Moore, Alisha; Thomas, Paul A; Roach, Paul; Back, Michael; Leonard, Robyn; Scott, Andrew M |
| 4 | 18-Mar-2020 | A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia. | Lickliter, Jason D; Gan, Hui K ; Voskoboynik, Mark; Arulananda, Surein; Gao, Bo; Nagrial, Adnan; Grimison, Peter; Harrison, Michelle; Zou, Jianjun; Zhang, Lianshan; Luo, Stacey; Lahn, Michael; Kallender, Howard; Mannucci, Andrea; Somma, Catello; Woods, Katherine; Behren, Andreas; Fernandez-Penas, Pablo; Millward, Michael; Meniawy, Tarek |
| 5 | Aug-2020 | A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History. | Prall, Owen William John; McEvoy, Christopher Robert Edward; Byrne, David John; Iravani, Amir; Browning, Judy; Choong, David Yew-Huong; Yellapu, Bhargavi; O'Haire, Sophie; Smith, Kortnye; Luen, Stephen James; Mitchell, Paul L R ; Desai, Jayesh; Fox, Stephen Bernard; Fellowes, Andrew; Xu, Huiling |
| 6 | 22-Jan-2020 | A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. | Alexander, Marliese; Pavlakis, Nick; John, Thomas ; O'Connell, Rachel; Kao, Steven; Hughes, Brett G M; Lee, Adrian; Hayes, Sarah A; Howell, Viive M; Clarke, Stephen J; Millward, Michael; Burbury, Kate; Solomon, Benjamin; Itchins, Malinda |
| 7 | 5-Dec-2018 | A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer. | Lindeman, Geoffrey J; Lok, Sheau Wen; Whittle, James R; Vaillant, Francois; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria J; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Zivanovic Bujak, Andjelija; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E |
| 408 | Mar-2019 | A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer. | Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J |
| 409 | Aug-2016 | A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. | Brandes, Alba A; Carpentier, Antoine F; Kesari, Santosh; Sepulveda-Sanchez, Juan M; Wheeler, Helen R; Chinot, Olivier; Cher, Lawrence M ; Steinbach, Joachim P; Capper, David; Specenier, Pol; Rodon, Jordi; Cleverly, Ann; Smith, Claire; Gueorguieva, Ivelina; Miles, Colin; Guba, Susan C; Desaiah, Durisala; Lahn, Michael M; Wick, Wolfgang |
| 410 | Oct-2018 | A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meeting. | Ameratunga, Malaka; Miller, Dorothea; Ng, Wayne; Wada, Morikatsu ; Gonzalvo, Augusto ; Cher, Lawrence M ; Gan, Hui K |
| 411 | 2019 | A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. | Arnaud-Coffin, Patrick; Maillet, Denis; Gan, Hui K ; Stelmes, Jean-Jacques; You, Benoit; Dalle, Stephane; Péron, Julien |
| 412 | 28-Jul-2021 | Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma. | Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Eftekhariyan Ghamsari, Mohammad Reza; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Cancer Study, Australian Ovarian; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L |
| 413 | 15-Sep-2021 | Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. | Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study, null; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L |
| 414 | Nov-2017 | Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study | Ahn, Myung-Ju; Kim, Dong-Wan; Chul Cho, Byoung; Kim, Sang-We; Lee, Jong Seok; Ahn, Jin-Seok; Kim, Tae Min; Lin, Chia-Chi; Kim, Hye Ryun; John, Thomas ; Kao, Steven; Goldman, Jonathan W; Su, Wu-hou; Natale, Ronald; Rabbie, Sarit; Harrop, Bryony; Overend, Philip; Yang, Zhenfan; Yang, James Chih-Hsin |
| 415 | 12-Aug-2022 | Acute Colonic Pseudo-Obstruction. | Arthur, Thomas; Burgess, Adele N |
| 416 | Sep-2023 | Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. | Huddart, R; Hafeez, S ; Omar, A; Alonzi, R; Birtle, A; Cheung, K C; Choudhury, A; Foroudi, Farshad ; Gribble, H; Henry, A; Hilman, S; Hindson, B; Lewis, R; Muthukumar, D; McLaren, D B; McNair, H; Nikapota, A; Olorunfemi, A; Parikh, O; Philipps, L; Rimmer, Y; Syndikus, I; Tolentino, A; Varughese, M; Vassallo-Bonner, C; Webster, A; Griffin, C; Hall, E |
| 417 | 1-Sep-2016 | The ADAM trial: visiting the road less traveled | Arulananda, Surein; John, Thomas |
| 418 | Feb-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Anton, Angelyn; Nottage, Michelle; Wong, Vanessa ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Lombard, Janine M; Gibbs, Peter; Gately, Lucy |
| 419 | 1-Jul-2006 | Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. | Mitchell, Paul L R ; Goldstein, David B; Michael, Michael; Beale, Philip; Friedlander, Michael; Zalcberg, John; White, Shane C; Thomson, Jacquelyn A; Clarke, Stephen |
| 420 | 23-Sep-2013 | Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. | Péron, Julien; Maillet, Denis; Gan, Hui K ; Chen, Eric X; You, Benoit |
